Helo Corp Announces Annual 2023 Results
Helo Corp Announces Annual 2023 Results
DUBLIN, IRELAND / ACCESSWIRE / April 24, 2024 / Helo Corp. (OTC PINK:HLOC) ("Helo" or the "Company"), a data-driven wellness technology company, announces its annual 2023 results.
愛爾蘭都柏林/ACCESSWIRE /2024年4月24日/Helo公司。(OTC PINK:HLOC)(“Helo”或“公司”),一家基於數據的健康科技公司,發佈了其2023年度業績。
Helo Corp Annual Results
Helo公司年度業績
2023 | 2022 | Change | ||||||||||
Revenue from Continuing Operations |
$ | 4,553,764 | $ | 1,221 | NM | |||||||
Revenue from Discontinued Operations |
$ | 2,899,378 | $ | 31,320,280 | NM | |||||||
Total Revenue |
$ | 7,453,142 | $ | 31,321,501 | (76)% | |||||||
Cost of Goods Sold* |
$ | 3,146,350 | $ | 7,031,066 | (55)% | |||||||
Gross Profit* |
58% | 78% | (25)% | |||||||||
SG&A* |
$ | 8,679,374 | $ | 25,266,079 | (66)% | |||||||
Operating Loss* |
$ | (4,372,582) | $ | (975,644) | 348% | |||||||
Operating Margin* |
(59)% | (3)% | NM | |||||||||
Net Income (Loss)* |
$ | 8,783,435 | $ | (463,731) | NM | |||||||
EPS - Basic* |
$ | 0.10 | $ | 0.00 | NM | |||||||
EPS - Diluted* |
$ | 0.03 | $ | 0.00 | NM |
2023 | 2022 | 變更 | ||||||||||
持續經營業務收入 |
$ | 4,553,764 | $ | 1,221 | 未出現數據 | |||||||
已停業務收入 |
$ | 2,899,378 | $ | 31,320,280 | 未出現數據 | |||||||
總收入 |
$ | 7,453,142 | $ | 31,321,501 | (76)% | |||||||
營業成本* |
$ | 3,146,350 | $ | 7,031,066 | (55)% | |||||||
毛利潤* |
58% | 78% | (25)% | |||||||||
銷售、一般和行政管理費用* |
$ | 8,679,374 | $ | 25,266,079 | (66)% | |||||||
營業虧損* |
$ | (4,372,582) | $ | (975,644) | 348% | |||||||
營業利潤率* |
(59)% | (3)% | 未出現數據 | |||||||||
淨利潤(虧損)* |
$ | 8,783,435 | $ | (463,731) | 未出現數據 | |||||||
每股收益 - 基本* |
$ | 0.10 | $ | 0.00 | 未出現數據 | |||||||
每股收益 - 稀釋* |
$ | 0.03 | $ | 0.00 | 未出現數據 |
* - includes results from continuing and discontinued operations
* - 包括持續和終止業務的成果
NM - the percentage change was not meaningful
未出現數據 - 百分比變化無意義
"In 2023 and into 2024, we executed our restructuring initiatives to significantly reduce our cost structure, leverage our existing technology and refocus Helo on the development of our NutraMatic and Helo AIplatform," said Sean McVeigh, Chief Executive Officer. "As we are currently tight on cash, we are seeking additional capital to fund the development and launch of these exciting innovations, which we believe will position us for substantial growth."
“在2023年和2024年初,我們執行了重組措施,大幅降低了成本結構,利用現有的技術,將Helo重新聚焦於NutraMatic和Helo人工智能平台的開發,”首席執行官肖恩·麥克維(Sean McVeigh)說:“由於我們的現金非常緊張,我們正在尋求額外的資金來支持這些令人興奮的創新產品的開發和推出,我們相信這將爲我們帶來巨大的增長。”
"2023 revenue from continuing operations was $4.6 million and from discontinued operations was $2.9 million, bringing our annual revenue for 2023 to $7.5 million, a decrease of 76% over the prior-year period," added David Ufheil, Chief Financial Officer. "Net Income for 2023 was $8.8 million, reflecting a $15.2 million increase in the fair value of VSC Coins that were issued to Helo in 2023, subject to a 24-month lock. We ended the year with total net assets of $19.1 million, and cash and cash equivalents of $0.3 million. The overall decline in results for 2023 reflects our shift in strategy to a new platform. In April 2024, we entered into an agreement to sell our Vyvo-focused subsidiaries. Accordingly, we have classified these operations as discontinued in our annual filing."
“2023年持續運營的營業收入爲$460萬,終止業務的營業收入爲$290萬,使我們的2023年年度營業收入達到$750萬,較去年同期下降了76%,”首席財務官大衛·烏夫海爾(David Ufheil)補充道:“2023年的淨利潤爲$880萬,反映出在2023年發行給Helo的VSC Coins的公允價值增加了$1520萬,但需要鎖定24個月。我們在年底的總淨資產爲$1910萬,現金及現金等價物爲$30萬。2023年業績總體下降反映了我們的策略轉變到新平台上。2024年4月,我們達成了出售Vyvo子公司的協議。相應地,我們在我們的年度報告中將這些業務分類爲已終止。”
About Helo Corp.
關於Helo Corp.
Helo Corp. (OTC:HLOC) is a data-driven wellness technology company. Helo wearables and other smart devices are built on Helo's Life Sensing Technology, which uses state-of-the-art sensors, enhanced signal processing, and algorithms to collect and process specific bio-parameters. Helo is developing the NutraMaticand Helo AI platform to leverage artificial intelligence and other technologies to analyze wearer data, provide personalized nutrition and recommendations, support the adoption of healthier lifestyle choices and drive human wellness transformation.
Helo Corp. (OTC:HLOC)是一家數據驅動的健康科技公司。Helo可穿戴設備和其他智能設備是基於Helo的生命感知技術構建的,該技術使用先進的傳感器,增強的信號處理和算法來收集和處理特定的生物參數。Helo正在開發NutraMatic和Helo人工智能平台,利用人工智能和其他技術分析佩戴者數據,提供個性化的營養和建議,支持採用更健康的生活方式選擇,並推動人類健康的轉型。helocorp.comHelo正在開發Nutramatic,該產品使用最先進的傳感器、增強信號處理和算法來收集和處理特定的生物參數。該公司的披露聲明和基本報表可以在OTC: HLOC上找到。
For more information please visit helocorp.com.
如需更多信息,請訪問OCT:HLOC.
The Company's disclosure statements and financial statements are available at OTC: HLOC.
公司的披露聲明和財務報表可以在此處查閱:場外交易:HLOC.
Forward Looking Statements
前瞻性聲明
This news release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "believes," and similar statements. All statements other than statements of historical fact in this press release are forward-looking statements and involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. These forward-looking statements are based on management's current expectations, assumptions, estimates and projections about the Company and the industry in which the Company operates, but involve a number of unknown risks and uncertainties. Further information regarding these and other risks is included in the Company's filings with the OTC Markets and the Securities and Exchange Commission. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and actual results may differ materially from the anticipated results. You are urged to consider these factors carefully in evaluating the forward-looking statements contained herein and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements.
本新聞發佈包含《證券法案》第27A條,經修訂的《證券交易法案》第21E條及1995年美國私人證券訴訟改革法案所規定的"前瞻性聲明"。這些前瞻性聲明可通過"將要","相信"等語言表述進行識別。本新聞稿中所有除歷史事實陳述外的語言均屬於前瞻性聲明且包含某些風險和不確定性因素,這些因素可能導致實際結果與前瞻性聲明中的結果有所不同。這些前瞻性聲明基於管理層對公司及公司所在行業的期望、假設、評估和預測,但涉及許多未知的風險和不確定性因素。有關這些及其他風險的詳細信息已包含在公司提交給OTC市場和美國證券交易委員會的備案中。除非依照法律規定,公司無義務更新前瞻性聲明以反映隨後發生的事件或情況,以及其期望的變化。儘管公司認爲這些前瞻性聲明是合理的,但它不能保證這些期望會變成現實,實際結果可能與預期結果有所不同。我們敦促您在評估其中包含的前瞻性聲明時,認真考慮這些因素,並注意不要過度依賴這些前瞻性聲明,它們已完全受到這些警告性聲明的限制。
Investors Contact:
investors@helocorp.com
650-646-2193
投資者聯繫方式:
investors@helocorp.com
650-646-2193
SOURCE: Helo Corp.
消息來源:Helo corp。